RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+16.76%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$6.22B
AUM Growth
+$6.22B
(+11%)
Cap. Flow
-$50.6M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
59.86%
Holding
75
New
7
Increased
28
Reduced
21
Closed
9
Top Buys
| 1 |
Fluor
FLR
|
$205M |
| 2 |
Viatris
VTRS
|
$107M |
| 3 |
Vistra
VST
|
$92.8M |
| 4 |
FTAI Aviation
FTAI
|
$86.2M |
| 5 |
PG&E
PCG
|
$50.2M |
Top Sells
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$471M |
| 2 |
Mr. Cooper
COOP
|
$87.1M |
| 3 |
Adaptive Biotechnologies
ADPT
|
$79.9M |
| 4 |
FLG
Flagstar Financial, Inc.
FLG
|
$74.7M |
| 5 |
Dole
DOLE
|
$60M |
Sector Composition
| 1 | Healthcare | 34.28% |
| 2 | Utilities | 30.97% |
| 3 | Industrials | 11.68% |
| 4 | Energy | 8.3% |
| 5 | Financials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adeia
ADEA
$1.64B
| $60.6M | 0.92% |
4,284,205
-50,926
| -1% | -$720K |
|
27
Zymeworks
ZYME
$1.12B
| $59.1M | 0.89% |
4,710,551
+372,107
| +9% | +$4.67M |
|
28
Liberty Global Class A
LBTYA
$4B
| $57M | 0.86% |
5,692,225
-310,426
| -5% | -$3.11M |
|
29
Delek US
DK
$1.67B
| $56.9M | 0.86% |
2,687,449
| – | – |
|
30
Heron Therapeutics
HRTX
$207M
| $55.3M | 0.84% |
26,713,503
| – | – |
|
|
31
Mr. Cooper
COOP
$12.1B
| $50.4M | 0.76% |
337,924
-583,613
| -63% | -$87.1M |
|
|
32
PG&E
PCG
$33.6B
| $50.2M | 0.76% |
+3,600,000
| New | +$50.2M |
|
33
Trevi Therapeutics
TRVI
$883M
| $46.7M | 0.71% |
8,531,860
+3,993,325
| +88% | +$21.8M |
|
34
Cannae Holdings
CNNE
$1.09B
| $43.9M | 0.66% |
2,105,864
+615,616
| +41% | +$12.8M |
|
35
Orthofix Medical
OFIX
$592M
| $41.5M | 0.63% |
3,721,715
+26,769
| +0.7% | +$298K |
|
|
MREO
36
Mereo BioPharma
MREO
$281M
| $41.5M | 0.63% |
15,307,347
| – | – |
|
37
Protolabs
PRLB
$1.19B
| $41.4M | 0.63% |
1,034,171
+918,219
| +792% | +$36.8M |
|
38
Ecovyst
ECVT
$1.04B
| $38.7M | 0.59% |
+4,707,347
| New | +$38.7M |
|
39
Liberty Global Class C
LBTYK
$4.07B
| $33.9M | 0.51% |
3,289,789
-3,729
| -0.1% | -$38.4K |
|
40
Xperi
XPER
$278M
| $32.8M | 0.5% |
4,143,744
| – | – |
|
41
The GEO Group
GEO
$2.94B
| $29.9M | 0.45% |
1,247,393
+571,502
| +85% | +$13.7M |
|
42
Mativ Holdings
MATV
$687M
| $27.2M | 0.41% |
3,982,442
-17,558
| -0.4% | -$120K |
|
43
Cimpress
CMPR
$1.55B
| $26.4M | 0.4% |
+561,429
| New | +$26.4M |
|
44
Integral Ad Science
IAS
$1.49B
| $24.7M | 0.37% |
2,971,951
-194,998
| -6% | -$1.62M |
|
45
MeiraGTx Holdings
MGTX
$587M
| $24.3M | 0.37% |
3,726,451
+1,950,130
| +110% | +$12.7M |
|
46
ARS Pharmaceuticals
SPRY
$1.15B
| $22.6M | 0.34% |
1,294,878
+265,777
| +26% | +$4.64M |
|
47
Supernus Pharmaceuticals
SUPN
$2.5B
| $21.9M | 0.33% |
+695,039
| New | +$21.9M |
|
48
Telesat
TSAT
$307M
| $20.6M | 0.31% |
843,781
-15,731
| -2% | -$384K |
|
49
Constellation Energy
CEG
$96B
| $17.6M | 0.27% |
+54,507
| New | +$17.6M |
|
50
scPharmaceuticals
SCPH
$295M
| $17.5M | 0.26% |
4,601,977
-173,023
| -4% | -$659K |
|